SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

SSgA Active Trust - SPDR S&P 500 ETF Trust

The market is focused on the expected interest rate decision, with community chatter split between anticipating a rally or a "sell the news" reaction. Many traders believe a 0.25% rate cut is already priced in, while others are closely watching Fed Chair Powell's commentary for further cues on the economic outlook and future monetary policy. Community members also discuss potential sector rotations and the impact of rate decisions on various asset classes.

Invesco Capital Management LLC - Invesco QQQ Trust Series 1

QQQ is trending as the market anticipates the Fed's rate decision, with widespread expectation of a 25 bps cut. Community members are closely watching Powell's tone and forward guidance, as well as potential sector rotations and the impact on small caps. Uncertainty surrounding inflation and labor market conditions adds to the speculation around the technology-heavy index.

Opendoor Technologies, Inc. engages in the operation of buying, selling, and trading of residential properties online. The company was founded by Eric Wu on December 30, 2013, and is headquartered in Tempe, AZ.

Opendoor Technologies Inc

Opendoor ($OPEN) is trending as traders anticipate potential benefits from upcoming interest rate decisions, with many highlighting the possibility of a short squeeze. The community is actively discussing the company's expansion plans and perceived advantages over traditional real estate, while also expressing strong opinions against short-sellers like Martin Shkreli. Speculation around potential rate cuts and their impact on the housing market fuels bullish sentiment.

Bitcoin is the first successful internet money based on peer-to-peer technology; whereby no central bank or authority is involved in the transaction and production of the Bitcoin currency. It was created by an anonymous individual/group under the name, Satoshi Nakamoto. The source code is available publicly as an open source project, anybody can look at it and be part of the developmental process.  Bitcoin is changing the way we see money as we speak. The idea was to produce a means of exchange, independent of any central authority, that could be transferred electronically in a secure, verifiable and immutable way. It is a decentralized peer-to-peer internet currency making mobile payment easy, very low transaction fees, protects your identity, and it works anywhere all the time with no central authority and banks.  Bitcoin is designed to have only 21 million BTC ever created, thus making it a deflationary currency. Bitcoin uses the SHA-256 hashing algorithm with an average transaction confirmation time of 10 minutes. Miners today are mining Bitcoin using ASIC chip dedicated to only mining Bitcoin, and the hash rate has shot up to peta hashes.  Being the first successful online cryptography currency, Bitcoin has inspired other alternative currencies such as Litecoin, Peercoin, Primecoin, and so on.  The cryptocurrency then took off with the innovation of the turing-complete smart contract by Ethereum which led to the development of other amazing projects such as EOS, Tron, and even crypto-collectibles such as CryptoKitties.

Bitcoin

Bitcoin is trending as traders anticipate potential impacts from upcoming Fed guidance on interest rates, with some expecting a significant move. Community members are also actively discussing new Solana token mints and memecoin opportunities associated with Bitcoin. Many are positioning themselves for a potential breakout, while others remain cautious, anticipating a possible "sell the news" event following any announcement.

BlackRock Institutional Trust Company N.A. - iShares Russell 2000 ETF

iShares Russell 2000 ETF

IWM is trending due to anticipation surrounding a potential Federal Reserve rate cut, with the market pricing in possible easing. Community discussions revolve around the impact of rate cuts on small-cap stocks and whether the expected news is already priced in, potentially leading to a "sell the news" event. Traders are closely watching for signals about the Fed's future policy and its effects on various sectors, especially small caps.

Snap, Inc. operates as a technology company, which engages in the provision of a visual messaging application that was created to help people communicate through short videos and images. The company was founded by Frank Reginald Brown IV, Evan Thomas Spiegel, and Robert C. Murphy in 2010 and is headquartered in Santa Monica, CA.

Snap Inc - Ordinary Shares - Class A

Snap Inc

Snap is trending amid high trading volume and speculation around a potential role in the TikTok deal, with buyout rumors adding to the buzz. The community is actively discussing the possibility of a short squeeze and potential for the stock to reach double digits soon. Optimism is fueled by the company's pivot towards growth initiatives and the potential of their AR technology.

TOSHI

TOSHI.X is trending amid community excitement around new exchange listings, particularly in South Korea, and speculation about potential future listings on major platforms like Binance. Talk of a recent partnership with Coinbase is circulating, as well as anticipation surrounding potential interest rate cuts and their impact on the crypto market. The community is also actively discussing the coin's technical outlook and potential for significant gains.

Gorilla Technology Group, Inc. engages in the provision of video intelligence, Internet of Things (IoT) security, edge AI data analytics, and operational technology security solutions and services in Asia Pacific. It operates through the following segments: Video IoT, Security Convergence, and Other. The company was founded by Spincer Koh in May 2001 and is headquartered in London, the United Kingdom.

Gorilla Technology Group Inc

Gorilla Technology (GRRR) is trending following news of a signed $1.4 billion contract to build AI-powered data centers in Southeast Asia with Freyr, causing significant excitement in the community. While some express skepticism about the partnership and question the market's reaction, many believe GRRR is undervalued compared to its peers, considering the size of the contract relative to its market cap. The community is also anticipating potential catalysts from the upcoming O.N.E Amazon event.

BlackRock Institutional Trust Company N.A. - iShares 20+ Year Treasury Bond ETF

iShares 20+ Year Treasury Bond ETF

TLT is trending as traders anticipate potential Fed rate cuts following recent economic data and await upcoming CPI and PPI reports, leading to discussions about recession risks and the bond market's next move. Community perspectives range from expectations of a bond rally to concerns about stagflation, with some highlighting the influence of tariffs and potential central bank actions. The conversation also involves analysis of technical indicators and potential trading strategies.

SSgA Active Trust - SPDR Dow Jones Industrial Average ETF

The SPDR Dow Jones Industrial Average ETF ($DIA) is trending as community members discuss potential market dips and corrections, referencing historical patterns and divinatory methods. Broader market sentiment is also in focus, particularly regarding upcoming Fed meetings and their potential impact on monetary policy. Microsoft's influence as a technology holding within the ETF also appears to be a driver of interest.

statis crypto Watchlist

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

RedHill Licenses RHB-102 for Commercialization Worldwide Excluding North America to Hyloris for up to $60 Million in Potential Milestone Payments Plus Royalties

RedHill Licenses RHB-102 for Commercialization Worldwide Excluding North America to Hyloris for up to $60 Million in Potential Milestone Payments Plus Royalties RedHill Licenses RHB-102 for...

RedHill Announces Initiation of Phase 2 Study of Opaganib and Darolutamide in Advanced Prostate Cancer

RedHill Announces Initiation of Phase 2 Study of Opaganib and Darolutamide in Advanced Prostate Cancer RedHill Announces Initiation of Phase 2 Study of Opaganib and Darolutamide in Advanced Prostate...

RedHill's Talicia Adds 8 Million Lives With Coverage by Humana's Part D Plan. Also, New Data Supporting Simplified Three-Times Daily Talicia Dosing Published

RedHill's Talicia Adds 8 Million Lives With Coverage by Humana's Part D Plan. Also, New Data Supporting Simplified Three-Times Daily Talicia Dosing Published RedHill's Talicia Adds 8 Million Lives...

Radioprotective Activity of RedHill's Opaganib for GI-ARS Confirmed in New RNCP/NIAID Study - Discussions Ongoing with U.S. Government on Advanced Development

Radioprotective Activity of RedHill's Opaganib for GI-ARS Confirmed in New RNCP/NIAID Study - Discussions Ongoing with U.S. Government on Advanced Development Radioprotective Activity of RedHill's...

RedHill Biopharma Awarded Judgment of Approximately $8 Million Plus Costs by New York Supreme Court

RedHill Biopharma Awarded Judgment of Approximately $8 Million Plus Costs by New York Supreme Court RedHill Biopharma Awarded Judgment of Approximately $8 Million Plus Costs by New York Supreme Court...

Actinium Pharmaceuticals Appoints Accomplished Biopharma Industry Executive June Almenoff, M.D., Ph.D. to its Board of Directors

Actinium Pharmaceuticals Appoints Accomplished Biopharma Industry Executive June Almenoff, M.D., Ph.D. to its Board of Directors Actinium Pharmaceuticals Appoints Accomplished Biopharma Industry...

RedHill Selected to Present Opaganib at Conference Organized by U.S. Government's JPEO-CBRND

RedHill Selected to Present Opaganib at Conference Organized by U.S. Government's JPEO-CBRND RedHill Selected to Present Opaganib at Conference Organized by U.S. Government's JPEO-CBRND PR Newswire...

RedHill Announces Collaboration with a Leading U.S. Academic Medical Center to Develop Opaganib as a Countermeasure Against Phosgene Inhalation Injury

RedHill Announces Collaboration with a Leading U.S. Academic Medical Center to Develop Opaganib as a Countermeasure Against Phosgene Inhalation Injury RedHill Announces Collaboration with a Leading...

RedHill Biopharma Secures U.S. Government Funding through BARDA to Advance Opaganib for Ebola Treatment

RedHill Biopharma Secures U.S. Government Funding through BARDA to Advance Opaganib for Ebola Treatment RedHill Biopharma Secures U.S. Government Funding through BARDA to Advance Opaganib for Ebola...

RedHill and Medi-Cal Deal Maintains Talicia Reimbursement Without Prior Authorization for 15 Million Californians

RedHill and Medi-Cal Deal Maintains Talicia Reimbursement Without Prior Authorization for 15 Million Californians RedHill and Medi-Cal Deal Maintains Talicia Reimbursement Without Prior Authorization...

RedHill Biopharma Ltd. engages in the development and commercialization of drugs for gastrointestinal (GI), infectious diseases, and oncology. The firm's products include Talicia, Movantik, and Aemcolo. It operates through the Commercial Operations and Research and Development segments. The Commercial Operations segment covers areas relating to commercial sales through a subsidiary in the United States. The Research and Development segment includes the study and licensing of therapeutic candidates. The company was founded by Dror Ben-Asher and Ori Shilo on August 3, 2009 and is headquartered in Tel Aviv, Israel.

Redhill Biopharma Ltd. - ADR

Just the one

Three

Four

The Fed just cut rates. How many cuts do you expect in all of 2025? 
 
*Powered by Polymarket

Current Price	$1.65
Prev Close	$1.52
Open	$1.53
Dividend Yield	0.00%
50-Day Moving Average	$1.56
Beta	0.85
Avg. Volume	106,913.76
PE Ratio	-0.02

52-Week High	$11.07
52-Week Low	$1.06
Market Capitalization	$5.06M
EPS (Annual)	-$6.73
Price to Book	-0.79
Revenue Per Employee	$230,890.69
Enterprise Value/EBITDA	N/A

RDHL
RedHill Biopharma Ltd.

Feed

News

Sentiment

Fundamentals

Info

Latest RDHL News

RDHL RedHill Biopharma Ltd.